No Data
No Data
Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment
USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage...
Merus (MRUS) Initiated With a Buy at Truist Financial
Bank of America Securities Remains a Buy on Merus (MRUS)
Merus Carcinoma Treatment Awarded US FDA's Breakthrough Therapy Designation
By Dean Seal Merus said federal regulators have granted breakthrough therapy designation to its carcinoma treatment petosemtamab.
Express News | FDA Grants Merus Breakthrough Therapy Designation For Petosemtamab For Treatment Of Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma
Express News | Merus NV: Plans to Provide Updated Efficacy, Durability and Safety Data From This Cohort in Second Half of 2024
No Data